Strength
150 [USP'U]/mL
Manufacturer
Antares Pharma, Inc.NDC
18657011704
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
HYALURONIDASE (HUMAN RECOMBINANT)Approval Type
Biologic (BLA)
FDA Application
BLA021859On Market Since
12/2/2005
Pharmacological Classes
Endoglycosidase
Glycoside Hydrolases
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.